Inhibition of HIV-1 replication by uridine-3'-spiroxirane, a new type of reverse transcriptase inhibitor.
Bailey
J M
JM
George Washington Univ. Medical School, Washington, D.C., USA.
Nelson
K A
KA
D000818:Animals; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D054303:HIV Reverse Transcriptase / Q000737:chemistry / Q000378:metabolism; D015497:HIV-1 / Q000187:drug effects / Q000502:physiology*; D006736:Horses; D006801:Humans; D004860:Infectious Anemia Virus, Equine / Q000187:drug effects / Q000502:physiology*; D008715:Methionine; D017354:Point Mutation; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology*; D013141:Spiro Compounds / Q000494:pharmacology*; D013601:T-Lymphocytes; D014529:Uridine / Q000031:analogs & derivatives* / Q000494:pharmacology; D014633:Valine; D014771:Virion / Q000187:drug effects / Q000502:physiology; D014779:Virus Replication / Q000187:drug effects*
D018894:Reverse Transcriptase Inhibitors; D013141:Spiro Compounds; D008715:Methionine; D054303:HIV Reverse Transcriptase; D014633:Valine; D014529:Uridine